Last reviewed · How we verify
NCT06747000
Lipoprotein Interactions and Platelet Function in Healthy Individuals and Those With Lipid Disorders
trial in Lipid Disorders in 80 participants. Currently enrolling.
18 July 2028
Quick facts
| Lead sponsor | The Miriam Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 18 July 2024 |
| Primary completion | 18 July 2028 |
| Estimated completion | 18 July 2029 |
| Sites | 2 locations across United States |
Conditions studied
- Lipid Disorders — all drugs for Lipid Disorders →
Sponsor
The Miriam Hospital
Who can join
Adults 18 to 69, any sex, with Lipid Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study looks at how lipoproteins, which are particles in the blood that transport cholesterol, influence heart and blood vessel health. Beyond just their levels, the way these particles function plays a key role in preventing or contributing to disease. In some conditions, like high cholesterol or diabetes, lipoproteins may not work properly, increasing the risk of clogged arteries and other complications. The investigators aim to study these changes in people with lipid disorders to better understand their impact on blood health and to find new ways to prevent and treat heart disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06747000
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other The Miriam Hospital trials
Trials by the same sponsor.
- NCT07228130 — Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment · NA · recruiting
- NCT07363616 — Pilot Test of Five Weight Neutral Interventions to Improve Health Among Adults of Higher Body Weight · NA · recruiting
- NCT06494488 — Differential Thrombogenesis by EPA and DHA Mediated by HDL · EARLY_PHASE1 · recruiting
- NCT06878872 — Type 1 Diabetes Adolescents for Healthier Lifestyles Study · NA · not yet recruiting
- NCT06875622 — Remote Approaches for Optimizing Weight Loss (Elevate Weight Loss Trial) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06747000 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Miriam Hospital
- Last refreshed: 1 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06747000.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing